Skip to main content
Caplight Logo









Wondercel Therapeutics

Wondercel Therapeutics

Private
ShenzhenHealthcare & Life Scienceshttps://www.wondercel.com/index

Last Round

Series A

Jul 10, 2026

Total Funding Raised

$33.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Wondercel Therapeutics is a biotechnology company that develops universal CAR-T cell therapy platforms for the treatment of cancer, organ transplantation, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T therapyallogeneic cell therapyoff-the-shelf cell therapybiotechnologyimmune cell therapycell therapy manufacturinginduced regulatory T celliTregimmune tolerancesolid tumor therapyhematologic malignanciesuniversal CAR-Tbiologicsclinical trialsnext-gen cell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wondercel Therapeutics Comparables

Compare Wondercel Therapeutics with similar companies based on industry and business-model similarity.

Wondercel Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qihan Biotech
83%
Allogene Therapeutics
75%
Legend Biotech
64%

Wondercel Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 10, 2026
AngelFeb 10, 2023

Wondercel Therapeutics Investors

Notable investors and investment history

Wondercel Therapeutics investors
InvestorRounds
Oriental Fortune CapitalSeries A
YuanBio Venture CapitalAngel
松禾资本 (Green Pine Capital Partners)Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2026

    $19.4M round with Oriental Fortune Capital and Green Pine Capital Partners.

Wondercel Therapeutics Filings

Explore SEC and related filing metadata, where available.

Wondercel Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Wondercel Therapeutics's valuation, stock price, and market status.

Is Wondercel Therapeutics a public or private company?

Wondercel Therapeutics is a private company.

What is the current stock price of Wondercel Therapeutics?

Wondercel Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Wondercel Therapeutics worth (valuation)?

Valuation information for Wondercel Therapeutics is not publicly available.

Can I buy Wondercel Therapeutics stock?

Wondercel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Wondercel Therapeutics's last funding round?

Wondercel Therapeutics's most recent funding round was Series A on July 10, 2026.

Who are the main investors in Wondercel Therapeutics?

Key investors in Wondercel Therapeutics include Oriental Fortune Capital, YuanBio Venture Capital, 松禾资本 (Green Pine Capital Partners).

Will Wondercel Therapeutics IPO soon?

No public IPO plans have been announced for Wondercel Therapeutics.

How can I track Wondercel Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wondercel Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShenzhen
Year Founded2022
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?